<DOC>
	<DOCNO>NCT00331994</DOCNO>
	<brief_summary>Primary objective : ass efficacy Bacillus clausii versus metronidazole eradication small intestinal bacterial overgrowth , 30 day end treatment . Secondary objective : ass efficacy Bacillus clausii versus metronidazole avoid recurrence small intestinal bacterial overgrowth , 90 day end treatment ; ass efficacy Bacillus clausiiversus metronidazole improve irritable bowel syndrome -related symptom ; ass efficacy Bacillus clausii versus metronidazole satisfactory relief overall irritable bowel syndrome symptom abdominal discomfort pain ; ass efficacy Bacillus clausii versus metronidazole improve irritable bowel syndrome quality life .</brief_summary>
	<brief_title>EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Inclusion criterion : Irritable bowel syndrome patient small intestinal bacterial overgrowth ( base positive lactulose glucose hydrogen breath test ) Patients able maintain usual diet lifestyle course study . Exclusion criterion : Pregnancy breastfeed Major concomitant disease ( include tumour hepatic and/or renal insufficiency ) Inflammatory bowel diseases History intestinal surgery ( except cholecystectomy appendectomy ) Use antibiotic , laxative , antidiarrheic drug probiotic ( medication dietetic supplement ) last month prior study entry Hypersensibility investigational product reference drug Clinical evidence relevant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematologic , neurologic disease may interfere patient successfully complete trial objective trial Eating disorder anorexia bulimia , and/or psychosis , schizophrenia , mania major psychiatric illness need pharmacological treatment . Wellcompensated depression exclude potential patient Participation trial previous three month Drug alcohol abuse Subjects unstable personality able compliant study procedures The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>